Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 18/20 | 0.61 |
| ▸ | PDE6C | P51160 | 3/20 | 0.61 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.58 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.58 |
| ▸ | PDE1A | P54750 | 2/20 | 0.58 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.58 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.58 |
| ▸ | PDE2A | O00408 | 1/20 | 0.58 |
| ▸ | ABCC5 | O15440 | 1/20 | 0.58 |
| ▸ | PDE6D | O43924 | 1/20 | 0.58 |
| ▸ | PDE8A | O60658 | 1/20 | 0.58 |
| ▸ | PDE9A | O76083 | 1/20 | 0.58 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | PDE6A | P16499 | 1/20 | 0.58 |
| ▸ | PDE6G | P18545 | 1/20 | 0.58 |
| ▸ | PDE4A | P27815 | 1/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21378257 | 0.95 | PDE5A (0.59) | PDE5APDE6CPDE3BPDE3APDE1A | |
| Water SCHEMBL28695299 | 0.94 | PDE5A (0.59) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL28412134 | 0.93 | PDE5A (0.60) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL28409225 | 0.92 | PDE5A (0.61) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL28485561 | 0.89 | PDE5A (0.49) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL21401289 | 0.89 | PDE5A (0.49) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL28417263 | 0.89 | PDE5A (0.58) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL28409118 | 0.89 | PDE5A (0.58) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL28412272 | 0.86 | PDE5A (0.45) | PDE5APDE6CPDE3BPDE3APDE1A | |
| SCHEMBL145682 | 0.83 | PDE5A (0.77) | PDE5APDE6CPDE3BPDE3APDE1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111732593-A | Piperazine oxide derivative and composition, preparation method and application thereof | 黄泳华 | 2020-10-02 | — | — | CN | claimed |
| CN-111297868-A | Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases | 黄泳华 | 2020-06-19 | — | — | CN | claimed |
| EP-3553060-B1 | POLYCRYSTALLINE MESYLATE OF PHOSPHODIESTERASE TYPE 5 INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | JINAN MEILUWEI BIOTECHNOLOGY CO LTD (CN) | 2020-12-23 | — | — | EP | disclosed |
| CN-111732593-A | Piperazine oxide derivative and composition, preparation method and application thereof | 黄泳华 | 2020-10-02 | — | — | CN | disclosed |
| CN-111297868-A | Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases | 黄泳华 | 2020-06-19 | — | — | CN | disclosed |
| US-10654859-B2 | Methanesulfonate polymorph of 5-type phosphodiesterase inhibitor and preparation method and applications thereof | Jinan Meiluwei Biotechnology Co., Ltd. (CN) | 2020-05-19 | — | — | US | disclosed |
| US-10654859-B2 | Methanesulfonate polymorph of 5-type phosphodiesterase inhibitor and preparation method and applications thereof | Jinan Meiluwei Biotechnology Co., Ltd. (CN) | 2020-05-19 | — | — | US | disclosed |
| EP-3553060-A1 | POLYCRYSTALLINE MESYLATE OF PHOSPHODIESTERASE TYPE 5 INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Jinan Meiluwei Biotechnology Co., Ltd. (CN) | 2019-10-16 | — | — | EP | disclosed |
| US-20190292192-A1 | METHANESULFONATE POLYMORPH OF 5-TYPE PHOSPHODIESTERASE INHIBITOR AND PREPARATION METHOD AND APPLICATIONS THEREOF | WANG, Jinglin (CN) | 2019-09-26 | — | — | US | disclosed |
| US-20190292192-A1 | METHANESULFONATE POLYMORPH OF 5-TYPE PHOSPHODIESTERASE INHIBITOR AND PREPARATION METHOD AND APPLICATIONS THEREOF | WANG, Jinglin (CN) | 2019-09-26 | — | — | US | disclosed |
| WO-2018209809-A1 | POLYCRYSTALLINE MESYLATE OF PHOSPHODIESTERASE TYPE 5 INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 王靖林 | 2018-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292192-A1 | METHANESULFONATE POLYMORPH OF 5-TYPE PHOSPHODIESTERASE INHIBITOR AND PREPARATION METHOD AND APPLICATIONS THEREOF | PDE5A, PDE3A, PDE9A | PDE5A 1/4885PDE6C 20/4885PDE3B 4/4885 |
| US-10654859-B2 | Methanesulfonate polymorph of 5-type phosphodiesterase inhibitor and preparation method and applications thereof | PDE5A, PDE3A, PDE9A | PDE5A 1/4885PDE6C 20/4885PDE3B 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.